Volume 29, issue 10, October 2022

79 articles in this issue

1. 23rd Annual Meeting of the American Society of Breast Surgeons: Back to In-Person Scientific Exploration

2. This is the Moment…

3. Keynote Address at the ASBrS 2022 Annual Meeting Low-Risk Breast Cancer: When Is Local Therapy Enough?

4. ASO Video Abstract: Keynote Address at the ASBrS 2022 Annual Meeting. Low-Risk Breast Cancer—When Is Local Therapy Enough?

5. Supraclavicular and Contralateral Axillary Lymph Node Involvement in Breast Cancer Patients

6. Inflammatory Breast Cancer: Is There a Role for Deescalation of Surgery?

7. ASO Visual Abstract: Inflammatory Breast Cancer—Is There a Role for De-escalation of Surgery?

8. Male Breast Cancer Patient and Surgeon Experience: The Male WhySurg Study

9. ASO Visual Abstract: Male Breast Cancer Patients and Surgeon Experience: The Male WhySurg Study

10. Is Nodal Clipping Beneficial for Node-Positive Breast Cancer Patients Receiving Neoadjuvant Chemotherapy?

11. ASO Author Reflections: Do We Need to Clip Metastatic Lymph Nodes at Diagnosis and Localize Them After Neoadjuvant Chemotherapy?

12. ASO Visual Abstract: Is Nodal Clipping Beneficial for Node-Positive Breast Cancer Patients Receiving Neoadjuvant Chemotherapy?

13. Innovation in Breast Surgery: Practical and Ethical Considerations

14. Margin Management and Adjuvant Therapy for Phyllodes Tumors: Practice Patterns of the American Society of Breast Surgeons Members

15. ASO Visual Abstract: Margin Management and Adjuvant Therapy for Phyllodes Tumors—Practice Patterns of the American Society of Breast Surgeons Members

16. Does Breast-Conserving Surgery with Radiotherapy have a Better Survival than Mastectomy? A Meta-Analysis of More than 1,500,000 Patients

17. Impact of COVID-19 Restrictions on Stage of Breast Cancer at Presentation and Time to Treatment at an Urban Safety-Net Hospital

18. ASO Visual Abstract: Does Breast-Conserving Surgery with Radiotherapy Have a Better Survival Than Mastectomy? A Meta-Analysis of More Than 1,500,000 Patients

19. Text-Based Intervention Increases Mammography Uptake at an Urban Safety-Net Hospital

20. ASO Visual Abstract: Text-Based Intervention Increases Mammography Uptake at an Urban Safety-Net Hospital

21. Accuracy of Posttreatment Imaging for Evaluation of Residual in Breast Disease After Neoadjuvant Endocrine Therapy

22. ASO Visual Abstract: Accuracy of Post-Treatment Imaging in the Evaluation of Residual in Breast Disease After Neoadjuvant Endocrine Therapy

23. Outcomes of Abbreviated MRI (Ab-MRI) for Women of any Breast Cancer Risk and Breast Density in a Community Academic Setting

24. ASO Author Reflection: Outcomes of Abbreviated MRI for Women of Any Breast Cancer Risk and Breast Density

25. ASO Visual Abstract: Outcomes of Abbreviated MRI (Ab-MRI) for Women of Any Breast Cancer Risk and Breast Density in a Community Academic Setting

26. Breast-Specific Sensuality in Breast Cancer Survivors: Sexually Active or Not

27. ASO Author Reflections: Breast-Specific Sensuality in the Sexually Inactive Breast Cancer Survivor

28. ASO Visual Abstract: Breast-Specific Sensuality in Breast Cancer Survivors – Sexually Active or Not

29. No One-Size-Fits-All: Sexual Health Education Preferences in Patients with Breast Cancer

30. ASO Visual Abstract: No One-Size-Fits-All: Sexual Health Education Preferences in Patients with Breast Cancer

31. Nodal Pathologic Complete Response Rates in Luminal Breast Cancer Vary by Genomic Risk

32. ASO Visual Abstract: Nodal Pathologic Complete Response Rates in Luminal Breast Cancer Vary by Genomic Risk

33. How Often Do Sentinel Lymph Node Biopsy Results Affect Adjuvant Therapy Decisions Among Postmenopausal Women with Early-Stage HR+/HER2− Breast Cancer in the Post-RxPONDER Era?

34. ASO Visual Abstract: How Often Do Sentinel Lymph Node Biopsy Results Affect Adjuvant Therapy Decisions Among Postmenopausal Women with Early-Stage HR+/HER2− Breast Cancer in the Post-RxPONDER Era?

35. Node Positivity Among Sonographically Suspicious but FNA-Negative Axillary Nodes

36. Economic Impact of Reducing Reexcision Rates after Breast-Conserving Surgery in a Large, Integrated Health System

37. ASO Visual Abstract: Economic Impact of Reducing Re-excision Rates After Breast-Conserving Surgery in a Large, Integrated Health System

38. Impact of Locoregional Treatment on Survival in Young Patients with Early-Stage Breast Cancer undergoing Upfront Surgery

39. ASO Author Reflections: Breast-Conserving Therapy: A Safe Option in Young Patients with Early-Stage Breast Cancer

40. ASO Visual Abstract: Impact of Locoregional Treatment on Survival in Young Patients with Early-Stage Breast Cancer Undergoing Upfront Surgery

41. Practice Patterns of Antibiotic Prophylaxis in Patients Undergoing Mastectomy: A Survey of Members of the American Society of Breast Surgeons

42. ASO Author Reflections: Perioperative Antibiotic Prophylaxis for Mastectomy—Too Much or Too Little

43. ASO Visual Abstract: Practice Patterns of Antibiotic Prophylaxis in Patients Undergoing Mastectomy—A Survey of Members of the American Society of Breast Surgeons

44. Intervention for Hepatic and Pulmonary Metastases in Breast Cancer Patients: Prospective, Multi-institutional Registry Study–IMET, Protocol MF 14-02

45. ASO Visual Abstract: Intervention for Hepatic and Pulmonary METastases in Breast Cancer Patients—Prospective, Multi-Institutional Registry Study: IMET; Protocol MF 14-02

46. Primary Breast Neuroendocrine Tumors: An Analysis of the National Cancer Database

47. ASO Author Reflections: Rare Breast Cancer Subtypes and the Role for Precision Oncology

48. ASO Visual Abstract: Primary Breast Neuroendocrine Tumors—An Analysis of the National Cancer Database

49. Risk of Lobular Neoplasia Upgrade with Synchronous Carcinoma

50. ASO Author Reflections: Is Surgical Excision Necessary in Lobular Neoplasia with Synchronous Breast Carcinoma?

51. ASO Visual Abstract: Risk of Lobular Neoplasia Upgrade with Synchronous Carcinoma

52. Stage IV Non-breast Cancer Patients and Screening Mammography: It is Time to Stop

53. ASO Author Reflections: It is Time to Deescalate Screening Mammography for Patients Who Do Not Benefit

54. ASO Visual Abstract: Stage IV Non-Breast Cancer Patients and Screening Mammography: It is Time to Stop

55. Lymphedema in Inflammatory Breast Cancer Patients Following Trimodal Treatment

56. ASO Visual Abstract: Lymphedema in Inflammatory Breast Cancer Patients Following Trimodal Treatment

57. Long-term Oncologic Outcomes in Patients with Inflammatory Breast Cancer with Supraclavicular Nodal Involvement

58. ASO Author Reflections: Inflammatory Breast Cancer with Supraclavicular Nodal Involvement–Favorable Long-Term Outcomes can be Achieved

59. Postoperative Hematomas in the Era of Outpatient Mastectomy: Is Ketorolac Really to Blame?

60. ASO Author Reflections: Weighing the Risks and Benefits of Multimodal Analgesia Following Breast Surgery

61. ASO Visual Abstract: Postoperative Hematomas in the Era of Outpatient Mastectomy: Is Ketorolac Really to Blame?

62. Machine Learning-Based Epigenetic Classifiers for Axillary Staging of Patients with ER-Positive Early-Stage Breast Cancer

63. ASO Author Reflections: Molecular Signatures May Render Surgical Staging of the Axilla Obsolete

64. ASO Visual Abstract: Machine Learning-Based Epigenetic Classifiers for Axillary Staging of Patients with ER-Positive Early-Stage Breast Cancer

65. Black Women Are Less Likely to Be Classified as High-Risk for Breast Cancer Using the Tyrer-Cuzick 8 Model

66. ASO Visual Abstract: Black Women Are Less Likely to Be Classified as High Risk for Breast Cancer Using Tyrer–Cuzick 8 Model

67. Analysis of the Understanding and Worry about Lymphedema of Patients with Breast Cancer

68. ASO Visual Abstract: Analysis of Breast Cancer Patients’ Understanding and Worry About Lymphedema

69. A Systematic Review and Meta-Analysis on the Role of Repeat Breast-Conserving Surgery for the Management of Ipsilateral Breast Cancer Recurrence

70. ASO Author Reflections: Surgical De-escalation for the Management of Ipsilateral Breast Cancer Recurrence in the Modern Era of Multimodality Treatment

71. ASO Visual Abstract: A Systematic Review and Meta-analysis on the Role of Repeat Breast-Conserving Surgery for the Management of Ipsilateral Breast Cancer Recurrence

72. Lack of Clinical Value for Immunohistochemistry for Sentinel Lymph Node Assessment in Invasive Lobular Carcinoma

73. ASO Author Reflections: Standardizing Pathology Examination of Sentinel Lymph Nodes in Invasive Lobular Carcinoma: Less Is More

74. ASO Visual Abstract: Lack of Clinical Value for Immunohistochemistry for Sentinel Lymph Node Assessment in Invasive Lobular Carcinoma

75. Guideline-Consistent Treatment for Inflammatory Breast Cancer Provides Associated Survival Benefit Independent of Age

76. ASO Author Reflections: Inflammatory Breast Cancer: The Exception to De-escalation of Care for Older Women?

77. ASO Visual Abstract: Guideline-Consistent Treatment for Inflammatory Breast Cancer Provides Associated Survival Benefit Independent of Age

78. The Influence of Body Mass Index on the Histopathology and Outcomes of Patients Diagnosed with Atypical Breast Lesions

79. ASO Visual Abstract: The Influence of BMI on the Histopathology and Outcomes of Patients with a Diagnosis of Atypical Breast Lesions